Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia

Clinical and Experimental Nephrology
Takashi WadaShuzo Kobayashi

Abstract

Diabetic nephropathy is a leading cause of end-stage kidney disease in the world. Although various types of treatment for diabetes, hypertension and dyslipidemia have improved prognosis and quality of life in patients with diabetic nephropathy, there still exist some diabetic patients with severe proteinuria showing poor prognosis. This clinical trial, LICENSE, aims to confirm the impact of LDL apheresis on proteinuria exhibiting hyporesponsiveness to treatment. This ongoing trial is a multicenter, prospective study of diabetic patients with severe proteinuria. The objective is to examine the impact of LDL apheresis on proteinuria in patients with diabetic nephropathy. The other subject is to investigate safety of LDL apheresis in these patients. The subjects consist of diabetic patients with serum creatinine (Cr) levels below 2 mg/dL who present severe proteinuria above 3 g/g Cr or 3 g/day and LDL cholesterol above 120 mg/dL. The target number of registered patients will be 35 patients. Urinary protein excretion and renal function will be observed for 24 weeks after the treatment of LDL apheresis. This study will determine the effectiveness and safety of LDL apheresis for diabetic nephropathy patients with severe proteinuria a...Continue Reading

References

Jan 1, 1994·Nephron·C Guijarro, W F Keane
Feb 8, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tsukasa NakamuraHikaru Koide
Oct 4, 2013·Diabetes Care·Miho ShimizuUNKNOWN Kanazawa Study Group for Renal Diseases and Hypertension
Oct 18, 2013·Clinical and Experimental Nephrology·Takashi WadaUNKNOWN Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan
Nov 8, 2013·Clinical and Experimental Nephrology·Tadashi ToyamaTakashi Wada

❮ Previous
Next ❯

Citations

Aug 29, 2020·Clinical and Experimental Nephrology·Takashi WadaUNKNOWN LICENSE study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.